Patents by Inventor Benedict Aurian-Blajeni

Benedict Aurian-Blajeni has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180357926
    Abstract: A system and method for guided or unguided instruction, comprising a color, or/and a tactilely coded list of most common ions, and a set, of blocks corresponding to a chart, sufficient to represent formula units in any possible combination of ions coded in the chart, is provided. A valid ionic compound (formula unit) model constructed with the present invention is represented by a rectangular, or cuboid, shape having six sides and eight corners and no more than two ionic types represented by blocks having ionic coding.
    Type: Application
    Filed: May 7, 2018
    Publication date: December 13, 2018
    Inventor: Benedict Aurian-Blajeni
  • Publication number: 20160203736
    Abstract: A block model kit for representing validly constructed ionic compounds is provided. A valid ionic compound (formula unit) constructed with the block model kit is represented by a cuboid shape having six faces and eight corners and no more than two ionic types represented by blocks having ionic coding.
    Type: Application
    Filed: July 8, 2015
    Publication date: July 14, 2016
    Inventor: Benedict Aurian-Blajeni
  • Patent number: 7526334
    Abstract: A technique and apparatus therefor adapted to treat in situ specified tissue, especially a malignant tumor, use being made of electrodes implanted in the tissue at spaced positions. Applied across the electrodes is a voltage causing a current to flow through the tissue to be treated. This current in one embodiment of the invention produces an electrochemical reaction yielding multiple reaction products, some of which are cytotoxic agents destructive of cancer cells, the voltage being regulated to optimize the yield of those agents having the greatest efficacy. In another embodiment, fed to the tissue is one or more reagents which when current flows through the tissue react with the material of an electrode to yield a cytotoxic agent in situ. Alternatively, the surface of the electrode can serve as a catalyst for the formation of the cytotoxic agents.
    Type: Grant
    Filed: June 26, 2003
    Date of Patent: April 28, 2009
    Assignee: Innovations Holdings, L.L.C.
    Inventors: Ewa Herbst, Benedict Aurian-Blajeni
  • Publication number: 20040059388
    Abstract: A technique and apparatus therefor adapted to treat in situ specified tissue, especially a malignant tumor, use being made of electrodes implanted in the tissue at spaced positions. Applied across the electrodes is a voltage causing a current to flow through the tissue to be treated. This current in one embodiment of the invention produces an electrochemical reaction yielding multiple reaction products, some of which are cytotoxic agents destructive of cancer cells, the voltage being regulated to optimize the yield of those agents having the greatest efficacy. In another embodiment, fed to the tissue is one or more reagents which when current flows through the tissue react with the material of an electrode to yield a cytotoxic agent in situ. Alternatively, the surface of the electrode can serve as a catalyst for the formation of the cytotoxic agents.
    Type: Application
    Filed: June 26, 2003
    Publication date: March 25, 2004
    Inventors: Ewa Herbst, Benedict Aurian-Blajeni
  • Patent number: 6708066
    Abstract: A technique and apparatus therefor adapted to treat in situ specified tissue, especially a malignant tumor, use being made of electrodes implanted in the tissue at spaced positions. Applied across the electrodes is a voltage causing a current to flow through the tissue to be treated. This current in one embodiment of the invention produces an electrochemical reaction yielding multiple reaction products, some of which are cytotoxic agents destructive of cancer cells, the voltage being regulated to optimize the yield of those agents having the greatest efficacy. In another embodiment, fed to the tissue is one or more reagents which when current flows through the tissue react with the material of an electrode to yield a cytotoxic agent in situ. Alternatively, the surface of the electrode can serve as a catalyst for the formation of the cytotoxic agents.
    Type: Grant
    Filed: December 8, 2000
    Date of Patent: March 16, 2004
    Inventors: Ewa Herbst, Benedict Aurian-Blajeni
  • Publication number: 20010021868
    Abstract: A technique and apparatus therefor adapted to treat in situ specified tissue, especially a malignant tumor, use being made of electrodes implanted in the tissue at spaced positions. Applied across the electrodes is a voltage causing a current to flow through the tissue to be treated. This current in one embodiment of the invention produces an electrochemical reaction yielding multiple reaction products, some of which are cytotoxic agents destructive of cancer cells, the voltage being regulated to optimize the yield of those agents having the greatest efficacy. In another embodiment, fed to the tissue is one or more reagents which when current flows through the tissue react with the material of an electrode to yield a cytotoxic agent in situ. Alternatively, the surface of the electrode can serve as a catalyst for the formation of the cytotoxic agents.
    Type: Application
    Filed: December 8, 2000
    Publication date: September 13, 2001
    Inventors: Ewa Herbst, Benedict Aurian-Blajeni
  • Patent number: 6021347
    Abstract: A technique and apparatus therefor adapted to treat in situ a malignant tumor, use being made of a working electrode and a counterelectrode implanted in the tumor at spaced positions. Applied across the electrodes is a voltage causing a direct current to flow through the tumor producing an electrochemical reaction yielding multiple reaction products, some of which are cytotoxic agents destructive of cancer cells. Coupled to the electrodes is a control unit which acts to regulate the voltage applied thereto so as to optimize the yield of those cytotoxic agents having the greatest efficacy.
    Type: Grant
    Filed: December 4, 1997
    Date of Patent: February 1, 2000
    Inventors: Ewa Herbst, Benedict Aurian-Blajeni
  • Patent number: 4478699
    Abstract: A device for the photosynthetic reduction of carbon dioxide and water by sunlight to formic acid, formaldehyde and methanol in the presence of semiconducting photoactive materials. Using preferred compositions of photoactive materials, selected from oxides and sulfides of copper, iron, molybdenum, ruthenium, lead, titanium, and from mixtures of any of these, and from barium titanate, calcium titanate, and strontium titanate, this photochemical solar collector also achieves photothermal energy conversion, thus providing the energy required for continuous distillation and recovery of the above organic materials produced.
    Type: Grant
    Filed: April 22, 1981
    Date of Patent: October 23, 1984
    Assignee: Yeda Research & Development Company, Ltd.
    Inventors: Martin M. Halmann, Mira Ulman, Benedict Aurian-Blajeni